Picture of AbCellera Biologics logo

ABCL — AbCellera Biologics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Brief: Abcellera Biologics Says Under Agreement, Regeneron Has Right To Develop And Commercialize Therapeutic Antibodies Resulting From Collaboration

Sept 20 (Reuters) - Abcellera Biologics Inc  ABCL.O :
    * ABCELLERA EXPANDS MULTI-TARGET ANTIBODY DISCOVERY
COLLABORATION
WITH REGENERON
    * ABCELLERA BIOLOGICS INC:  UNDER AGREEMENT, REGENERON HAS
RIGHT
TO DEVELOP AND COMMERCIALIZE THERAPEUTIC ANTIBODIES RESULTING
FROM COLLABORATION
    * ABCELLERA BIOLOGICS: UNDER DEAL, CO GETS RESEARCH
PAYMENTS,
ELIGIBLE TO GET DOWNSTREAM CLINICAL, REGULATORY MILESTONE
PAYMENTS, ROYALTIES ON NET SALES

Source text for Eikon:  ID:nBw5g4BqQa 
Further company coverage:  ABCL.O 

 ((Reuters.Briefs@thomsonreuters.com))

Recent news on AbCellera Biologics

See all news